| Year |
Citation |
Score |
| 2023 |
Barak S, Goltseker K. New Approaches for Alcohol Use Disorder Treatment via Memory Retrieval and Reconsolidation Manipulations. Current Topics in Behavioral Neurosciences. PMID 36627475 DOI: 10.1007/7854_2022_411 |
0.82 |
|
| 2022 |
Parikh S, Parikh R, Michael K, Bikovski L, Barnabas G, Mardamshina M, Hemi R, Manich P, Goldstein N, Malcov-Brog H, Ben-Dov T, Glaich O, Liber D, Bornstein Y, Goltseker K, ... ... Barak S, et al. Food-seeking behavior is triggered by skin ultraviolet exposure in males. Nature Metabolism. PMID 35817855 DOI: 10.1038/s42255-022-00587-9 |
0.74 |
|
| 2021 |
Even-Chen O, Herburg L, Kefalakes E, Urshansky N, Grothe C, Barak S. FGF2 is an endogenous regulator of alcohol reward and consumption. Addiction Biology. e13115. PMID 34796591 DOI: 10.1111/adb.13115 |
0.498 |
|
| 2021 |
Barak S, Goltseker K. Targeting the Reconsolidation of Licit Drug Memories to Prevent Relapse: Focus on Alcohol and Nicotine. International Journal of Molecular Sciences. 22. PMID 33920982 DOI: 10.3390/ijms22084090 |
0.823 |
|
| 2020 |
Goltseker K, Handrus H, Barak S. Disruption of relapse to alcohol seeking by aversive counterconditioning following memory retrieval. Addiction Biology. e12935. PMID 32657509 DOI: 10.1111/Adb.12935 |
0.842 |
|
| 2020 |
Liran M, Rahamim N, Ron D, Barak S. Growth Factors and Alcohol Use Disorder. Cold Spring Harbor Perspectives in Medicine. PMID 31964648 DOI: 10.1101/Cshperspect.A039271 |
0.604 |
|
| 2020 |
Edemann-Callesen H, Barak S, Hadar R, Winter C. Choosing the Optimal Brain Target for Neuromodulation Therapies as Alcohol Addiction Progresses—Insights From Pre-Clinical Studies Current Addiction Reports. 7: 237-244. DOI: 10.1007/S40429-020-00316-W |
0.519 |
|
| 2019 |
Maier HB, Neyazi M, Neyazi A, Hillemacher T, Pathak H, Rhein M, Bleich S, Goltseker K, Sadot-Sogrin Y, Even-Chen O, Frieling H, Barak S. Alcohol consumption alters Gdnf promoter methylation and expression in rats. Journal of Psychiatric Research. 121: 1-9. PMID 31710958 DOI: 10.1016/J.Jpsychires.2019.10.020 |
0.817 |
|
| 2019 |
Even-Chen O, Barak S. Inhibition of FGF receptor-1 suppresses alcohol consumption: role of PI3 kinase signaling in dorsomedial striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31375540 DOI: 10.1523/Jneurosci.0805-19.2019 |
0.583 |
|
| 2019 |
Gera R, Barak S, Schonberg T. Counterconditioning following memory retrieval diminishes the reinstatement of appetitive memories in humans. Scientific Reports. 9: 9213. PMID 31239475 DOI: 10.1038/S41598-019-45492-6 |
0.322 |
|
| 2018 |
Goltseker K, Hopf FW, Barak S. Advances in behavioral animal models of alcohol use disorder. Alcohol (Fayetteville, N.Y.). PMID 30424979 DOI: 10.1016/J.Alcohol.2018.05.014 |
0.833 |
|
| 2018 |
Even-Chen O, Barak S. The role of fibroblast growth factor 2 in drug addiction. The European Journal of Neuroscience. PMID 30144335 DOI: 10.1111/Ejn.14133 |
0.41 |
|
| 2018 |
Ziv Y, Rahamim N, Lezmy N, Even-Chen O, Shaham O, Malishkevich A, Giladi E, Elkon R, Gozes I, Barak S. Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30008470 DOI: 10.1038/S41386-018-0132-7 |
0.574 |
|
| 2018 |
Goltseker K, Barak S. Flood-conditioned place aversion as a novel non-pharmacological aversive learning procedure in mice. Scientific Reports. 8: 7280. PMID 29740070 DOI: 10.1038/S41598-018-25568-5 |
0.759 |
|
| 2018 |
Barak S, Ahmadiantehrani S, Logrip ML, Ron D. GDNF and alcohol use disorder. Addiction Biology. PMID 29726054 DOI: 10.1111/Adb.12628 |
0.823 |
|
| 2017 |
Burstein O, Franko M, Gale E, Handelsman A, Barak S, Motsan S, Shamir A, Toledano R, Simhon O, Hirshler Y, Chen G, Doron R. Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression. Plos One. 12: e0188043. PMID 29141007 DOI: 10.1371/Journal.Pone.0188043 |
0.669 |
|
| 2017 |
Even-Chen O, Sadot-Sogrin Y, Shaham O, Barak S. Fibroblast growth factor 2 in the dorsomedial striatum is a novel positive regulator of alcohol consumption. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28821667 DOI: 10.1523/Jneurosci.0890-17.2017 |
0.586 |
|
| 2017 |
Zipori D, Sadot-Sogrin Y, Goltseker K, Even-Chen O, Rahamim N, Shaham O, Barak S. Re-exposure to nicotine-associated context from adolescence enhances alcohol intake in adulthood. Scientific Reports. 7: 2479. PMID 28559549 DOI: 10.1038/S41598-017-02177-2 |
0.826 |
|
| 2017 |
Goltseker K, Laufer H, Shaham O, Barak S. Aversive counterconditioning during reconsolidation prevents relapse of alcohol memories European Neuropsychopharmacology. 27: S98-S99. DOI: 10.1016/S0924-977X(17)30171-2 |
0.828 |
|
| 2017 |
Zipori D, Sadot-Sogrin Y, Goltseker K, Even-Chen O, Shaham O, Barak S. Retrieval of nicotine-associated memories from adolescence enhances alcohol intake in adulthood Alcohol. 60: 229-230. DOI: 10.1016/J.Alcohol.2017.02.295 |
0.814 |
|
| 2016 |
Goltseker K, Levi L, Barak S. Counterconditioning during Reconsolidation Prevents Relapse of Cocaine Memories. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27468918 DOI: 10.1038/Npp.2016.140 |
0.776 |
|
| 2016 |
Ron D, Barak S. Molecular mechanisms underlying alcohol-drinking behaviours. Nature Reviews. Neuroscience. PMID 27444358 DOI: 10.1038/Nrn.2016.85 |
0.693 |
|
| 2015 |
Logrip ML, Barak S, Warnault V, Ron D. Corticostriatal BDNF and alcohol addiction. Brain Research. PMID 25801118 DOI: 10.1016/J.Brainres.2015.03.025 |
0.818 |
|
| 2015 |
Barak S, Wang J, Ahmadiantehrani S, Ben Hamida S, Kells AP, Forsayeth J, Bankiewicz KS, Ron D. Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse. Addiction Biology. 20: 629-42. PMID 24801661 DOI: 10.1111/Adb.12152 |
0.839 |
|
| 2014 |
Carnicella S, Ron D, Barak S. Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse. Alcohol (Fayetteville, N.Y.). 48: 243-52. PMID 24721195 DOI: 10.1016/J.Alcohol.2014.01.006 |
0.796 |
|
| 2014 |
Neasta J, Barak S, Hamida SB, Ron D. mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse. Journal of Neurochemistry. 130: 172-84. PMID 24666346 DOI: 10.1111/Jnc.12725 |
0.538 |
|
| 2014 |
Ahmadiantehrani S, Barak S, Ron D. GDNF is a novel ethanol-responsive gene in the VTA: implications for the development and persistence of excessive drinking. Addiction Biology. 19: 623-33. PMID 23298382 DOI: 10.1111/Adb.12028 |
0.764 |
|
| 2013 |
Barak S, Liu F, Ben Hamida S, Yowell QV, Neasta J, Kharazia V, Janak PH, Ron D. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nature Neuroscience. 16: 1111-7. PMID 23792945 DOI: 10.1038/Nn.3439 |
0.689 |
|
| 2013 |
Warnault V, Darcq E, Levine A, Barak S, Ron D. Chromatin remodeling--a novel strategy to control excessive alcohol drinking. Translational Psychiatry. 3: e231. PMID 23423140 DOI: 10.1038/Tp.2013.4 |
0.796 |
|
| 2013 |
Davies DL, Bortolato M, Finn DA, Ramaker MJ, Barak S, Ron D, Liang J, Olsen RW. Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders. Alcoholism, Clinical and Experimental Research. 37: 8-15. PMID 22671690 DOI: 10.1111/J.1530-0277.2012.01846.X |
0.67 |
|
| 2012 |
Griebel G, Pichat P, Pruniaux MP, Beeské S, Lopez-Grancha M, Genet E, Terranova JP, Castro A, Sánchez JA, Black M, Varty GB, Weiner I, Arad M, Barak S, De Levie A, et al. SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents. Pharmacology, Biochemistry, and Behavior. 102: 203-14. PMID 22542742 DOI: 10.1016/J.Pbb.2012.04.004 |
0.625 |
|
| 2012 |
Barak S, Ben Hamida S. Memory erasure, enhanced extinction and disrupted reconsolidation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2250-1. PMID 22396400 DOI: 10.1523/Jneurosci.6123-11.2012 |
0.314 |
|
| 2011 |
Barak S, Ahmadiantehrani S, Kharazia V, Ron D. Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption. Translational Psychiatry. 1. PMID 22238721 DOI: 10.1038/Tp.2011.57 |
0.829 |
|
| 2011 |
Barak S, Carnicella S, Yowell QV, Ron D. Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 9885-94. PMID 21734280 DOI: 10.1523/Jneurosci.1750-11.2011 |
0.825 |
|
| 2011 |
Barak S, Weiner I. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target. Pharmacology, Biochemistry, and Behavior. 99: 164-89. PMID 21420999 DOI: 10.1016/J.Pbb.2011.03.011 |
0.497 |
|
| 2011 |
Gibb SL, Jeanblanc J, Barak S, Yowell QV, Yaka R, Ron D. Lyn kinase regulates mesolimbic dopamine release: implication for alcohol reward. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 2180-7. PMID 21307254 DOI: 10.1523/Jneurosci.5540-10.2011 |
0.811 |
|
| 2011 |
Barak S, Weiner I. The Mâ‚/Mâ‚„ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1233-46. PMID 21211109 DOI: 10.1017/S1461145710001549 |
0.5 |
|
| 2011 |
Black MD, Stevens RJ, Rogacki N, Featherstone RE, Senyah Y, Giardino O, Borowsky B, Stemmelin J, Cohen C, Pichat P, Arad M, Barak S, De Levie A, Weiner I, Griebel G, et al. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Psychopharmacology. 215: 149-63. PMID 21181124 DOI: 10.1007/S00213-010-2124-0 |
0.625 |
|
| 2010 |
Wang J, Carnicella S, Ahmadiantehrani S, He DY, Barak S, Kharazia V, Ben Hamida S, Zapata A, Shippenberg TS, Ron D. Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14502-12. PMID 20980608 DOI: 10.1523/Jneurosci.3909-10.2010 |
0.743 |
|
| 2010 |
Barak S, Weiner I. Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine. Psychopharmacology. 209: 175-84. PMID 20179909 DOI: 10.1007/S00213-010-1785-Z |
0.504 |
|
| 2010 |
Barak S, Weiner I. Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuli. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1073-82. PMID 20072122 DOI: 10.1038/Npp.2009.210 |
0.502 |
|
| 2010 |
Ahmadiantehrani S, Barak S, Ron D. High levels of voluntary alcohol intake induces region-specific alterations in the expression of GDNF, an endogenous regulator of alcohol consumption F1000research. 1. DOI: 10.7490/F1000Research.700.1 |
0.835 |
|
| 2010 |
Barak S, Kharazia V, Ahmadiantehrani S, Ron D. Autoregulation of GDNF levels in the VTA induces long-lasting inhibition of excessive alcohol consumption F1000research. 1. DOI: 10.7490/F1000Research.668.1 |
0.832 |
|
| 2009 |
Barak S, Arad M, De Levie A, Black MD, Griebel G, Weiner I. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1753-63. PMID 19158670 DOI: 10.1038/Npp.2008.232 |
0.622 |
|
| 2009 |
Black MD, Varty GB, Arad M, Barak S, De Levie A, Boulay D, Pichat P, Griebel G, Weiner I. Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology. 202: 385-96. PMID 18709358 DOI: 10.1007/S00213-008-1289-2 |
0.623 |
|
| 2009 |
Barak S, Weiner I. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 227-41. PMID 18687163 DOI: 10.1017/S1461145708009176 |
0.499 |
|
| 2007 |
Barak S, Weiner I. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 989-99. PMID 16971898 DOI: 10.1038/Sj.Npp.1301208 |
0.516 |
|
| Show low-probability matches. |